Patent approved for CRISPR use in T-cells in Europe – UPI.com
UPI.com |
Patent approved for CRISPR use in T-cells in Europe
UPI.com The European Patent Office issued a patent today to the biopharmaceutical company Cellectis for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1 for the genetic engineering of T-cells. Photo courtesy of the National Human Genome … |
